Clinical studies recruiting near Geneva

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children
Phase N/A · Geneva University Hospitals · University Hospital, Geneva · NCT06998264 Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NA · University Hospital Geneva · University Hospital, Geneva · NCT06207383 Post-Stroke Fatigue Perception Study (ReFast)
Phase N/A · School of Health Sciences Geneva · NCT07444151 Virtual Reality Rehabilitation for Shoulder Pathologies
NA · La Tour Hospital · NCT06963983 Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors
Phase N/A · Hôpitaux Universitaires de Genève · University Hospital, Geneva · NCT07506356 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Clinique Générale-Beaulieu ( Site 2406) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Northwestern Medicine Cancer Center Delnor · National Cancer Institute (NCI) · NCT05564390 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · Hopiteaux Universitaires de Geneve · Vertex Pharmaceuticals Incorporated · NCT04786262 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Northwestern Medicine Cancer Center Delnor · NRG Oncology · NCT05624996 STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
NA · Geneva University Hospitals · IGLESIAS Juan Fernando · NCT05785897 The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
Phase 3 · University Hospital of Geneva · Centre Hospitalier Universitaire Vaudois · NCT05726786 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hôpital Universitaire de Genève (HUG) · Hoffmann-La Roche · NCT06793215 Spontaneous Coronary Artery Dissection National Swiss Registry
Phase N/A · Geneva University Hospitals · Dr. Sophie Degrauwe · NCT04457544 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Hopitaux Universitaires de Geneve · Amgen · NCT07037433 Swiss Revision Cohort
Phase N/A · Orthopedic Surgery Service, Geneva University Hospitals · Insel Gruppe AG, University Hospital Bern · NCT07473089 Swiss Registry for Neuromuscular Disorders
Phase N/A · University Hospitals of Geneva, Children's Hospital · University of Bern · NCT05102916 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Northwestern Medicine Cancer Center Delnor · PrECOG, LLC. · NCT06538038 Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer
Phase 2 · Hôpitaux Universitaires Genève · Insel Gruppe AG, University Hospital Bern · NCT06274879 Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
Phase 4 · University Hospitals of Geneva · Laure Pittet, MD-PhD · NCT05758532 Swiss Multiple Sclerosis Cohort-Study
Phase N/A · University Hospital Geneva · University Hospital, Basel, Switzerland · NCT02433028 A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07357727 Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension
NA · Hopitaux Universitaires de Genève · AGIR à Dom · NCT02057783 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Northwestern Medicine Cancer Center Delnor · SWOG Cancer Research Network · NCT06769126 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Northwestern Medicine Cancer Center Delnor · NRG Oncology · NCT05946213 Neuro-biomechanical Determinants for Motor Behavior in High-risk Infants
Phase N/A · University Hospitals Geneva · University Hospital, Geneva · NCT06111898 Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · Hôpitaux Universitaires Genevois · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149 Air-polishing With Erythritol During Orthodontic Tretament
NA · University of Geneva, University Clinics of Dental Medicine · Catherine Giannopoulou · NCT05989750 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Northwestern Medicine Cancer Center Delnor · NRG Oncology · NCT06532279 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Hopitaux universitaires de Geneve · Amgen · NCT07005128 Diagnosis of Tuberculosis in Swiss Children
Phase N/A · Hôpital des enfants - HUG · University Children's Hospital Basel · NCT03044509

Look up another city

Look up another condition